Open AccessTreatment with Combinations of the Anti-HER2 Antibody Trastuzumab and Capecitabine in Advanced Metastatic Breast Cancer Patients – a Pilot Study
Author(s) -
Michael Braun,
B. Schlehe,
Andreé Faridi,
U. Heindrichs,
Christian Rudlowski
Publication year - 2007
Publication title -
breast care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.767
H-Index - 30
eISSN - 1661-3805
pISSN - 1661-3791
DOI - 10.1159/000105492
Subject(s) - medicine , capecitabine , trastuzumab , metastatic breast cancer , oncology , regimen , breast cancer , tolerability , progressive disease , taxane , cancer , chemotherapy , adverse effect , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom